Biogen Inc. buy Needham & Company LLC
Start price
28.06.24
/
50%
€212.90
Target price
28.06.25
€274.57
Performance (%)
-49.72%
End price
29.06.25
€107.05
Summary
This prediction ended on 29.06.25 with a price of €107.05. The BUY prediction by Needham___Company_LL for Biogen Inc. performed very badly with a performance of -49.72%. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -1.244% | -1.244% | 58.750% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten